麻豆传媒

Dr. Parker is a senior fellow for the Pandemic and Biosecurity Policy Programs at the Scowcroft Institute of International Affairs, Bush School of Government and Public Service; associate dean for Global One Health, Texas A&M College of Veterinary Medicine

Dr. Monique K. Mansoura joined The MITRE Corporation as the Executive Director for Global Health Security and Biotechnology in September 2017. She brings technical, policy and business expertise from both the public and private sectors. Her current efforts focus on the sustainability of the biodefense industrial base and the public-private partnerships that are vital to national and global health security as well as the bioeconomy. These issues are especially relevant to the challenges our nation and the world faces in addressing threats such as the 2019 Novel Coronavirus (2019-nCoV) and the surety and security of medical supply chains.

She is an internationally recognized executive in the biopharma industry and biomedical research and development ecosystem (industry, government, and academia) with proven success designing and driving missions of international importance through innovative public-private partnerships, particularly in market-challenged environments. She brings unique skills and perspectives given training and expertise in business, science, and policy. She has been deeply engaged with two of the most vital issues of our times 鈥� the Human Genome Project (1996-2001) and Biodefense/Global Health Security (2002-present) for threats including chemical, biological, radiological and nuclear (CBRN) agents, pandemic influenza and other emerging infectious diseases. Her pivotal career transition was driven by a call to service following 9/11 and the 2001 anthrax attacks. She led strategic policy, planning and budgeting for a pioneering multibillion-dollar medical countermeasure development and acquisition program in the U.S. that still stands a model for the world under the authorities of the Project BioShield Act of 2004 and the Pandemic and All-Hazards Preparedness Act of 2006. She has been a successful senior leader in Government and industry by building effective teams across diverse organizations and functions, developing talent, leveraging multi-stakeholder networks through effective engagement with partners in biotech and multinational companies, academia, professional and patient advocacy organizations and international governments through the Global Health Security Initiative. She served on the Board of the Alliance for Biosecurity from 2012-2016 and is currently on the Board of the International Cancer Expert Corps (ICEC).

During a recent sabbatical, Monique examined innovative financing approaches in healthcare as a Research Affiliate of the MIT Laboratory for Financial Engineering (LFE), Sloan School of Management. She led an LFE healthcare finance initiative in global health security with Professor Andrew Lo and his colleagues. This initiative explored new business models and financial vehicles for raising and deploying funds to enhance global health security.

In 2018, Dr. Mansoura participated in the Public-Private Analytic Exchange Program sponsored by the Office of the Director of National Intelligence. Her team developed a report in July 2018 on 鈥淭hreats to Pharmaceutical Supply Chains鈥� focusing on Hurricane Maria and the 2017-2018 seasonal influenza epidemic as a case study for the risks and implications of pharmaceutical supply chain disruptions.

Monique earned a PhD in Bioengineering and a M.S. in Human Genetics from the University of Michigan, a B.S. in Chemical Engineering from Wayne State University, and an MBA in the Sloan Fellows Program in Innovation and Global Leadership at MIT.

 
Brenda Anne Wilson is a Professor of microbiology in the School of Molecular & Cellular Biology at the University of Illinois Urbana-Champaign. She also is the Inaugural Professor of Biomedical and Translational Sciences in the Carle Illinois College of Medicine, an adjunct professor of pathobiology in the College of Veterinary Medicine; and the Sandia Senior Faculty Fellow in the university's Office of the Vice Chancellor for Research and Innovation. 
Wilson is a fellow of the American Academy of Microbiology and a member of the AAM Selection Committee, and an American Society for Microbiology Distinguished Lecturer.
She was a DAAD graduate exchange Fellow in biochemistry at Ludwig-Maximilians Universität München, Germany. While earning her PhD at Johns Hopkins University, she was an AAUW doctoral fellow and studied antibiotic biosynthesis. She then undertook her NIH postdoctoral fellowship training in microbiology at Harvard Medical School, where she began her studies on bacterial protein toxins. Her first tenured faculty appointment was in biochemistry at Wright State University School of Medicine, Dayton, Ohio.
As inaugural leader of the Host-Microbe Systems Theme of the Woese Institute for Genomic Biology at the University of Illinois for 10 years, Wilson brought together faculty and scientists from multiple disciplines across campus, including microbiology, anthropology, animal sciences, engineering, and veterinary pathobiology to forge new areas of microbiome research. She served for 10 years on the executive committee of the Great Lakes Regional Center for Excellence in Biodefense and Emerging Infectious Diseases. As co-director of the University of Illinois Center for Zoonoses Research, she has promoted the One-Health Initiative and training of DVM students in research through summer training experiences. For nearly 20 years she has served as Biosecurity Leader of the Executive Committee of the University of Illinois Program in Arms Control, Domestic and International Security, where she has engaged events promoting scientific literacy and bridging the gap between scientists and educators, policy makers, government officials, and the public.
Wilson is currently president of the Champaign-Urbana Branch of the American Association for University Women, where she helps organize and convene community outreach events aimed at advancing equity and higher education opportunities for women and girls, particularly in STEM areas. As director for undergraduate education in the School of Molecular and Cellular Biology, she helps oversee the delivery of all academic, advising, and curricular aspects of the BS in MCB, BS in Biochemistry, BS in Neuroscience, and the forthcoming BS in MCB + Data Science undergraduate programs and the MS in MCB graduate programs. As the Sandia Senior Faculty Fellow in the Office of the Vice-Chancellor for Research and Innovation, she fosters, engages, and sustains research collaborations in STEM disciplines, including building workforce pipelines between scientists at the University of Illinois and the U.S. Department of Energy's national labs.
Research interests
Wilson’s research focuses on the host-microbe interface, bacterial pathogenesis and bacterial protein toxins, development of anti-toxin and toxin-based therapeutic biologics, comparative and functional genomic technologies and applications involving microbiomes and their roles in health and disease, climate change impacts on microbiomes, health, and disease transmission, and development of technologies and applications for detection and risk assessment of Dual Use Research of Concern (DURC) objects, publications, and activities. She has published over 150 scientific articles, chapters, and books, including the highly acclaimed textbook Bacterial Pathogenesis: A Molecular Approach (4th Edition, 2019, ASM Press/John Wiley) and the recent Revenge of the Microbes: How Bacterial Resistance is Undermining the Antibiotic Miracle (2nd Edition, 2023, ASM Press/John Wiley).
Education
BA (Biochemistry and German), Barnard College/Columbia University, 1981
Biochemistry Diplomarbeit (Post-baccalaureate Program), Deutscher Akademischer Austauschdienst (DAAD), Ludwig-Maximilians Universität, Munich, Germany, 1981-1982
M.S./Ph.D. (Chemistry), Johns Hopkins University, 1989
Postdoctoral (Microbiology and Molecular Genetics), Harvard Medical School, 1989-1993
Website